DE69014974D1 - Impfstoff gegen Hundecoronavirus. - Google Patents

Impfstoff gegen Hundecoronavirus.

Info

Publication number
DE69014974D1
DE69014974D1 DE69014974T DE69014974T DE69014974D1 DE 69014974 D1 DE69014974 D1 DE 69014974D1 DE 69014974 T DE69014974 T DE 69014974T DE 69014974 T DE69014974 T DE 69014974T DE 69014974 D1 DE69014974 D1 DE 69014974D1
Authority
DE
Germany
Prior art keywords
coronavirus
dog vaccine
vaccine
dog
coronavirus dog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69014974T
Other languages
English (en)
Other versions
DE69014974T2 (de
Inventor
William Baxendale
William Stuart Kenned Chalmers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69014974D1 publication Critical patent/DE69014974D1/de
Application granted granted Critical
Publication of DE69014974T2 publication Critical patent/DE69014974T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69014974T 1989-05-03 1990-05-01 Impfstoff gegen Hundecoronavirus. Expired - Fee Related DE69014974T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89304441 1989-05-03

Publications (2)

Publication Number Publication Date
DE69014974D1 true DE69014974D1 (de) 1995-01-26
DE69014974T2 DE69014974T2 (de) 1995-05-18

Family

ID=8202669

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69014974T Expired - Fee Related DE69014974T2 (de) 1989-05-03 1990-05-01 Impfstoff gegen Hundecoronavirus.

Country Status (12)

Country Link
US (2) US5232694A (de)
EP (1) EP0396193B1 (de)
JP (1) JP2892767B2 (de)
KR (1) KR0142081B1 (de)
AU (1) AU630186B2 (de)
CA (1) CA2015828C (de)
DE (1) DE69014974T2 (de)
DK (1) DK0396193T3 (de)
ES (1) ES2068322T3 (de)
HU (1) HU214739B (de)
NZ (1) NZ233509A (de)
ZA (1) ZA903142B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
WO1998027433A1 (en) * 1996-12-18 1998-06-25 Engene Biotechnologies, Inc A specific diagnostic for antibodies to feline infectious peritonitis virus
AU2005200757A1 (en) * 2005-02-21 2006-09-07 Peter Henry Scott An Insect Attractant Composition and Trap Containing Same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
EP0138242A1 (de) * 1983-09-07 1985-04-24 Duphar International Research B.V Verfahren zur Herstellung von DNS,die Komplementär zum Genom von Coronaviren ist
WO1988001292A1 (en) * 1986-08-22 1988-02-25 Board Of Regents, The University Of Texas System Human enteric coronavirus
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine

Also Published As

Publication number Publication date
US5232694A (en) 1993-08-03
CA2015828A1 (en) 1990-11-03
KR900017611A (ko) 1990-12-19
HU214739B (hu) 2000-03-28
NZ233509A (en) 1992-05-26
HUT56287A (en) 1991-08-28
EP0396193B1 (de) 1994-12-14
DE69014974T2 (de) 1995-05-18
ZA903142B (en) 1991-02-27
JPH02295934A (ja) 1990-12-06
CA2015828C (en) 1999-07-13
AU5474190A (en) 1990-11-08
KR0142081B1 (ko) 1998-06-01
HU902644D0 (en) 1990-09-28
US5464621A (en) 1995-11-07
ES2068322T3 (es) 1995-04-16
DK0396193T3 (da) 1995-02-27
JP2892767B2 (ja) 1999-05-17
AU630186B2 (en) 1992-10-22
EP0396193A1 (de) 1990-11-07

Similar Documents

Publication Publication Date Title
FI906367A0 (fi) Terapeutiska nukleosider.
FI903382A0 (fi) Topiskt anbringbara farmaceutiska preparat.
FI913899A0 (fi) Terapeutiska aerosolblandningar.
DE69022750D1 (de) Bohrgerät.
DK272889D0 (da) Vaccine
DE59007669D1 (de) Lithotriptor.
DE59009528D1 (de) Carbonsäureamide.
DK189788D0 (da) Vaccine
FI920152A (fi) Kirurgisk borrschablon.
DE3888189D1 (de) Lithotripter.
DE3882781D1 (de) Impfstoff gegen pasteurella.
DE69026975D1 (de) Impfstoff gegen Coccidiosis
FI904854A0 (fi) Terapeutiska nukleosider.
DE68901510D1 (de) Heftverbandsbahn.
DE69021761D1 (de) Impfstoff gegen Tinea.
DE68907211D1 (de) Markierungsanordnung.
DE69020848D1 (de) Impfstoff gegen IBV.
DE69014974D1 (de) Impfstoff gegen Hundecoronavirus.
NO900442D0 (no) Vaksineblanding.
DE69006041D1 (de) Bukkale Anästhetika.
FI922311A (fi) Kuvett och lineariskt drivverk avsett foer den.
DE68927340D1 (de) Biologischer impfstoff, wirksam gegen aphanomyces
DE68918189D1 (de) Neisseria-Vakzine.
DE69006090D1 (de) Schornsteinfegegerät.
DE69001506D1 (de) Zementstrukturen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee